This inventor holds 59 USPTO granted patents, primarily in Solenoid Valve Technology (CPC class 1378). Top assignees: Smc Corporation, Banyu Pharmaceutical Co. Ltd, Merck Sharp + Dohme Corp.. Active years: 1995-2010.
Inventors with similar research interests:
Location History:
- Yawara, JP (1995)
- Yawara-mura, JP (1996 - 2000)
- Tsukuba-gun, JP (1997 - 2005)
- Tsukubamirai, JP (2009)
- Ibaraki, JP (1998 - 2010)
- Ushiku, JP (2010)
Company Filing History:
56 out of 1,490Â 
2 out of 237Â 
1 out of 2,405Â 
Years Active: 1995-2010
Areas of Expertise:
Title: **Innovations of Makoto Ishikawa: A Pioneer in Pharmaceutical Patents**
Introduction
Makoto Ishikawa, based in Tsukuba-gun, Japan, is a renowned inventor with an impressive portfolio of 59 patents. His work prominently features advancements in pharmaceutical sciences, showcasing his commitment to improving health outcomes through innovative inventions.
Latest Patents
Ishikawa's latest patents highlight significant contributions to medical treatments. One of his notable inventions includes melanin-concentrating hormone receptor antagonists containing piperidine derivatives. This invention provides a novel class of compounds aimed at treating various conditions related to obesity and metabolic disorders.
Another remarkable patent involves a glucokinase activator characterized by a 2-heteroaryl-substituted benzimidazole derivative. This innovation has potential applications as a remedy and preventive measure for diabetes, along with associated complications such as retinopathy, nephropathy, neurosis, ischemic cardiopathy, and arteriosclerosis. The detailed formula of this compound, which includes various structural components, underscores his expertise in medicinal chemistry.
Career Highlights
Throughout his career, Ishikawa has collaborated with prominent organizations such as SMC Corporation and Banyu Pharmaceutical Co. Ltd. These experiences have enriched his knowledge and broadened his impact in the pharmaceutical industry.
Collaborations
Ishikawa has also worked alongside notable colleagues, including Bunya Hayashi and Shinji Miyazoe. Their partnerships have led to innovative approaches and methodologies in drug development, further enhancing the efficacy of their research endeavors.
Conclusion
Makoto Ishikawa's journey as an inventor reflects his dedication to advancing healthcare through innovative solutions. With a robust portfolio of patents and successful collaboration with leading companies and talented colleagues, he continues to make significant strides in the realm of pharmaceutical inventions.